Pancreatic Cancer Research

ResearcherXuzhou Medical CollegeActive in the last 2 years

Lei Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9241-7019; OpenAlex author ID A5100331716. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
21
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 1 paper

Papers 6

  1. Imaging pancreatic cancer with [18F]F-AlF-NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT): distribution patterns and therapeutic implica… Co-author DOI 10.1016/j.crad.2025.106954↗
  2. hsa_circ_0007919 promotes pancreatic cancer metastasis by modulating Sp1-mediated THBS1 transcription. First author DOI 10.1096/fj.202302422rr↗
  3. Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancr… Co-author DOI 10.1186/s12943-024-01937-9↗
  4. N-glycan biosignatures as a potential diagnostic biomarker for early-stage pancreatic cancer. Co-author DOI 10.4251/wjgo.v16.i3.659↗
  5. hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal… Co-author DOI 10.1186/s12943-023-01887-8↗
  6. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer. Co-author DOI 10.1111/jcmm.15718↗

Closest collaborators

The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zeqiang Ren · 3 shared papers, 2023–2024 · strength 0.54
  2. Xiao Ma · 2 shared papers, 2024 · strength 0.38
  3. Yi Zhang · 2 shared papers, 2023–2024 · strength 0.35
  4. Pengbo Zhang · 2 shared papers, 2023–2024 · strength 0.35
  5. Pengbo Zhang · 2 shared papers, 2020–2024 · strength 0.28
  6. Jinbo Yue · 1 shared paper, 2025 · strength 0.25
  7. C. Wang · 1 shared paper, 2025 · strength 0.25
  8. Yan-Rong Wen · 1 shared paper, 2024 · strength 0.24
  9. Jian He · 1 shared paper, 2024 · strength 0.24
  10. Shouji Cao · 1 shared paper, 2020 · strength 0.09
  11. Zipeng Lu · 1 shared paper, 2020 · strength 0.09
  12. Qun Chen · 1 shared paper, 2020 · strength 0.09
  13. Meng Cao · 1 shared paper, 2020 · strength 0.09
  14. Tianfang Xia · 1 shared paper, 2020 · strength 0.09
  15. Guodong Shi · 1 shared paper, 2020 · strength 0.09
  16. Lei Chen · 1 shared paper, 2020 · strength 0.09
  17. Pengfei Wu · 1 shared paper, 2020 · strength 0.09
  18. Xinquan Wu · 1 shared paper, 2020 · strength 0.09
  19. Yi Miao · 1 shared paper, 2020 · strength 0.09
  20. Baobao Cai · 1 shared paper, 2020 · strength 0.09
  21. Kuirong Jiang · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.